BRCA1 and ovarian carcinoma: Genetic cancer risk assessment (GCRA) is recommended for women with a personal or family history of breast or ovarian cancer who are at risk of carrying deleterious mutations of the BRCA1/2 genes (Daly et al. 2021; US Preventive Services Task Force et al. 2019).